Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06320236Recruiting

Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Role: lead

NCT07536906Not Yet Recruiting

Falls Validation Study

Role: lead

NCT05364749Recruiting

Selective CT for Anticoagulated Head Injured Patients

Role: lead

NCT06195787Completed

Improving Emergency Department Testing for Deep Vein Thrombosis

Role: lead

NCT05708794Completed

Adjust-Unlikely PE

Role: lead

All 5 trials loaded